NCT02916927View on ClinicalTrials.gov

Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Pain
Interventions
DRUG

Ketamine IV Infusion

Ketamine 0.3 mg/kg in 100mL normal saline minibag administered over 15 min and placebo 10 mL normal saline syringe administered over 1 minute.

DRUG

Ketamine IV push

Ketamine 0.3 mg/kg in 10 mL normal saline syringe administered over 1 minute and placebo 100mL normal saline minibag administered over 15 min.

Trial Locations (1)

94602

Alameda Health System, Highland Hospital, Oakland

All Listed Sponsors
lead

Alameda Health System

OTHER

NCT02916927 - Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department | Biotech Hunter | Biotech Hunter